S100A6 acts as a calcium-regulated switch that facilitates biosynthetic VEGFR trafficking, enabling the integration of signaling and trafficking pathways in endothelial cells.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Colin Baigent (2002) studied this question. S100A6 depletion was evaluated on VEGFR signaling and trafficking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: